EUROAPI Stock

Equities

EAPI

FR0014008VX5

Pharmaceuticals

Market Closed - Euronext Paris 11:35:29 2024-04-19 am EDT 5-day change 1st Jan Change
2.682 EUR +3.63% Intraday chart for EUROAPI -4.08% -53.19%
Sales 2024 * 917M 977M Sales 2025 * 969M 1.03B Capitalization 254M 271M
Net income 2024 * -81M -86.28M Net income 2025 * -11M -11.72M EV / Sales 2024 * 0.39 x
Net Debt 2024 * 103M 110M Net Debt 2025 * 28M 29.83M EV / Sales 2025 * 0.29 x
P/E ratio 2024 *
-3.1 x
P/E ratio 2025 *
-21.6 x
Employees 3,329
Yield 2024 *
-
Yield 2025 *
0.28%
Free-Float 70.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.63%
1 week-4.08%
Current month-4.04%
1 month+1.51%
3 months-53.92%
6 months-44.06%
Current year-53.19%
More quotes
1 week
2.51
Extreme 2.51
2.88
1 month
2.38
Extreme 2.383
3.09
Current year
2.26
Extreme 2.26
7.02
1 year
2.26
Extreme 2.26
12.97
3 years
2.26
Extreme 2.26
19.02
5 years
2.26
Extreme 2.26
19.02
10 years
2.26
Extreme 2.26
19.02
More quotes
Managers TitleAgeSince
Chief Executive Officer - Jan. 03
Director of Finance/CFO - 20-01-31
Chairman 60 21-06-30
Members of the board TitleAgeSince
Director/Board Member 67 22-05-05
Director/Board Member 52 23-01-10
Director/Board Member 46 23-02-21
More insiders
Date Price Change Volume
24-04-19 2.682 +3.63% 517,641
24-04-18 2.588 -3.22% 290,384
24-04-17 2.674 -1.76% 183,037
24-04-16 2.722 -1.66% 197,377
24-04-15 2.768 -1.00% 358,194

Real-time Euronext Paris, April 19, 2024 at 11:35 am EDT

More quotes
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 6 production sites located in France (2), the United Kingdom, Germany, Italy and Hungary.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
2.682 EUR
Average target price
4.72 EUR
Spread / Average Target
+75.99%
Consensus

Quarterly revenue - Rate of surprise